/Companies

Pacific Diabetes Technologies

Portland, US · Founded 2021 · Delaware corporation

Find your way into Pacific Diabetes Technologies

Sign up to see every warm intro you have to Pacific Diabetes Technologies

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Pacific Diabetes Technologies team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Pacific DT develops a patented prototype system emerging from university research with support from major health foundations and government agencies. The company is transitioning from research stage toward commercial clinical applications.

Founders & leadership

Pacific Diabetes Technologies was founded in 2021 by W. Kenneth Ward.

WKW. Kenneth Ward
W. Kenneth WardCo-Founder
TSThomas Seidel
Thomas SeidelExecutive

Board

EL
Edward La CavaBoard director
KW
Ken WardBoard director
PE
Peter EckenbergCEO, Director
YB
Yobie BenjaminBoard director

Reported raises · per SEC filings

Form D private placements

$7M disclosed across 3 of 4 rounds · 2021–2025

▶$3.4MraisedNov 2025 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas SeidlExecutive Officer, Director, Promoter
  • Hank WuhDirector
  • Christopher MarshDirector
Offering amount
$3.5M
Amount sold
$3.4M
First sale
Oct 2025
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.1MraisedMar 2025 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Hank WuhDirector
  • Mark HuberDirector
  • Peter EckenbergDirector
  • Christopher MarshDirector
  • Kenneth WardDirector
  • Thomas SeidlExecutive Officer, Director
  • Ed La CavaDirector
Offering amount
$5M
Amount sold
$2.1M
First sale
Mar 2025
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedSep 2024 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Edward La CavaDirector
  • Ken WardDirector
  • Thomas SeidelExecutive Officer, Director
  • Peter EckenbergDirector
  • Yobie BenjaminDirector
Offering amount
$5M
Amount sold
$1.5M
Minimum investment
$250K
First sale
Sep 2023
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MofferedJun 2021 · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas SeidelExecutive Officer
Offering amount
$2M
Minimum investment
$25K
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

Companies working in the same space as Pacific Diabetes Technologies.

In the news

Frequently asked questions

What does Pacific Diabetes Technologies do?
Pacific DT develops a patented prototype system emerging from university research with support from major health foundations and government agencies. The company is transitioning from research stage toward commercial clinical applications.
Who founded Pacific Diabetes Technologies?
Pacific Diabetes Technologies was founded by W. Kenneth Ward in 2021.
How much funding has Pacific Diabetes Technologies raised?
Pacific Diabetes Technologies has disclosed $7M raised across 3 of its 4 known rounds.
Where is Pacific Diabetes Technologies headquartered?
Pacific Diabetes Technologies is headquartered in Portland, US.